These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26104177)

  • 1. Reversible Cardiomyopathy After Epirubicin Administration.
    Koitabashi N; Ohyama Y; Tateno R; Arai M; Rokutanda N; Horiguchi J; Kurabayashi M
    Int Heart J; 2015; 56(4):466-8. PubMed ID: 26104177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.
    Meinardi MT; van Veldhuisen DJ; Gietema JA; Dolsma WV; Boomsma F; van den Berg MP; Volkers C; Haaksma J; de Vries EG; Sleijfer DT; van der Graaf WT
    J Clin Oncol; 2001 May; 19(10):2746-53. PubMed ID: 11352968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anthracycline induced cardiomyopathy in 51-years old women with breast cancer].
    Biskup P; Wozakowska-Kapłon B; Góźdź S
    Pol Arch Med Wewn; 2006 Jun; 115(6):551-8. PubMed ID: 17263227
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal doxorubicin in breast cancer: new preparation. Much ado about nothing.
    Prescrire Int; 2003 Jun; 12(65):93-5. PubMed ID: 12825572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme inhibitor in the treatment of epirubicin-induced dilated cardiomyopathy].
    Jensen BV; Nielsen SL; Jensen TS
    Ugeskr Laeger; 1997 Mar; 159(13):1945-9. PubMed ID: 9123633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline cardiotoxicity: one size does not fit all!
    Hershman DL; Neugut AI
    J Natl Cancer Inst; 2008 Aug; 100(15):1046-7. PubMed ID: 18664649
    [No Abstract]   [Full Text] [Related]  

  • 10. Doxorubicin-induced cardiomyopathy 17 years after chemotherapy.
    Kumar S; Marfatia R; Tannenbaum S; Yang C; Avelar E
    Tex Heart Inst J; 2012; 39(3):424-7. PubMed ID: 22719160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
    Appel JM; Sogaard P; Mortensen CE; Skagen K; Nielsen DL
    J Am Soc Echocardiogr; 2011 Feb; 24(2):200-6. PubMed ID: 21227647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin in combination with the taxanes.
    Trudeau M; Pagani O
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):41-50. PubMed ID: 11552229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.
    Vulsteke C; Pfeil AM; Maggen C; Schwenkglenks M; Pettengell R; Szucs TD; Lambrechts D; Dieudonné AS; Hatse S; Neven P; Paridaens R; Wildiers H
    Breast Cancer Res Treat; 2015 Jul; 152(1):67-76. PubMed ID: 26017071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy.
    Shipman KE; Arnold I
    J Clin Oncol; 2011 Jun; 29(18):e537-8. PubMed ID: 21482996
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients.
    Jensen BV; Skovsgaard T; Nielsen SL
    Ann Oncol; 2002 May; 13(5):699-709. PubMed ID: 12075737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scorpion-related cardiomyopathy: Clinical characteristics, pathophysiology, and treatment.
    Abroug F; Souheil E; Ouanes I; Dachraoui F; Fekih-Hassen M; Ouanes Besbes L
    Clin Toxicol (Phila); 2015 Jul; 53(6):511-8. PubMed ID: 25851549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of early epirubicin cardiotoxicity in women with breast cancer.
    Sobić-Saranović D; Pavlović S; Susnjar S; Neskovi c-Konstantinović Z; Jelić S
    Anticancer Res; 1997; 17(5B):3889-91. PubMed ID: 9427798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet).
    Leonard RC; Williams S; Tulpule A; Levine AM; Oliveros S
    Breast; 2009 Aug; 18(4):218-24. PubMed ID: 19656681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature.
    Framarino-dei-Malatesta M; Perrone G; Giancotti A; Ventriglia F; Derme M; Iannini I; Tibaldi V; Galoppi P; Sammartino P; Cascialli G; Brunelli R
    BMC Cancer; 2015 Dec; 15():951. PubMed ID: 26673573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.